v3 Template
A

Akeso

Biopharmaceutical Hong Kong ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$250.0M
Funding Rounds
1
Last Funding
2024-10-13

About Akeso

Akeso, Inc. (Kangfang Biotech) is a pioneering Chinese biopharmaceutical company founded by an experienced international team. It focuses on major disease areas such as tumors, autoimmune diseases, inflammation, and metabolic disorders, addressing unmet clinical needs globally. The company has developed a unique end-to-end drug research and development platform (ACE Platform), incorporating innovative technologies like Tetrabody bispecific antibody development, antibody-drug conjugate (ADC), mRNA, and cell therapy. Akeso aims to deliver affordable, innovative antibody drug solutions for patients worldwide through efficient and breakthrough R&D, striving to become a leading global biopharmaceutical enterprise.

Products & Services

Product Pipeline:Focused on addressing unmet medical needs in oncology, autoimmune diseases, inflammation, and metabolic disorders globally.
Innovative Antibody Drugs:Development of first-in-class and best-in-class new drugs for global patients.

Specialties

Oncology Autoimmune Diseases Inflammation Metabolic Disorders Tetrabody Bispecific Antibody Technology Antibody-Drug Conjugate (ADC) Technology mRNA Technology Cell Therapy

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Share Placement
T: -
FT: Share Placement
A: 250000000
MR: -
FA: approximately $250 million USD
FAN: 250000000
D: 2024-10-13
FD: 2024-10-13
2 investors
Share Placement Latest
2024-10-13
$250.0M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

夏 瑜

Founder, Chairman, President and Chief Executive Officer

李百勇

Co-founder, Executive Vice President, Chief Scientific Officer

王忠民

Co-Founder, Senior Vice President

张 鹏

Co-Founder, Senior Vice President

夏 羽

Senior Vice President

王秉中

Chief Financial Officer

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Akeso Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~220 employees (est.)
Locations
Hong Kong
Hong Kong and San Francisco, California
Hong Kong, China

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro